LINCOLN- Senator Kate Bolz has introduced legislation to improve insulin affordability in Nebraska.
The legislation proposes to cap patient out of pocket expenses for prescription insulin drugs to no more than $100 per month. The bill would be suspended if it results in an insurance premium increase of more than 3 percent. According to the American Medical Association, over the past fourteen years, the out of pocket cost of many insulin brands increased 555% adjusted for inflation. The Association says nearly 1 in 4 diabetics have reported rationing or skipping insulin doses because of cost.
Bolz said they can’t continue a situation where 1 in 10 Nebraskans rely on a drug that doubles in price every few years.